MilliporeSigma
All Photos(2)

Documents

HT17MG-14K-PX25

Millipore

MILLIPLEX® Human TH17 Magnetic Bead Panel Premixed - 25 Plex - Immunology Multiplex Assay

Simultaneously analyze multiple Th17 cytokine and chemokine biomarkers with the Th17 Bead-Based Multiplex Assays using the Luminex technology, in human serum, plasma and cell culture samples.

Sign Into View Organizational & Contract Pricing

Synonym(s):
Human Th17 cytokine multiplex kit, Luminex® human Th17 cytokine immunoassay, Millipore human Th17 cytokine panel
eCl@ss:
32161000

Quality Level

species reactivity

human

manufacturer/tradename

Milliplex®

assay range

accuracy: 79-107%
standard curve range: 1-5000 pg/mL
(IL-10)

standard curve range: 10-40,000 pg/mL
(IFNγ)

standard curve range: 12-50,000 pg/mL
(IL-17A & IL-2)

standard curve range: 24-100,000 pg/mL
(IL-17 & IL-4)

standard curve range: 3-10,000 pg/mL
(IL-6 & TNFα)

standard curve range: 336-1,500,000 pg/mL
(IL-23)

standard curve range: 37-150,000 pg/mL
(IL-22 & TNFβ)

standard curve range: 488-2,000,000 pg/mL
(IL-17E/IL-25)

standard curve range: 49-200,000 pg/mL
(IL-28a & IL-31)

standard curve range: 5-20,000 pg/mL
(MIP-3α, IL-1β, IL-12 (p70), IL-15, IL-21 & IL-33)

standard curve range: 6-25,000 pg/mL
(IL-5)

standard curve range: 61-250,000 pg/mL
(GM-CSF & IL-27)

standard curve range: 7-30,000 pg/mL
(IL-13)

standard curve range: 9-35,000 pg/mL
(IL-9)

technique(s)

multiplexing: suitable

compatibility

configured for Premixed

detection method

fluorometric (Luminex xMAP)

shipped in

wet ice

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
HTH17MAG-14KMT17MAG47K-PX25HCD8MAG-15K
manufacturer/tradename

Milliplex®

manufacturer/tradename

Milliplex®

manufacturer/tradename

Milliplex®

manufacturer/tradename

Milliplex®

assay range

accuracy: 79-107%, standard curve range: 1-5000 pg/mL
(IL-10), standard curve range: 10-40,000 pg/mL
(IFNγ), standard curve range: 12-50,000 pg/mL
(IL-17A & IL-2), standard curve range: 24-100,000 pg/mL
(IL-17 & IL-4), standard curve range: 3-10,000 pg/mL
(IL-6 & TNFα), standard curve range: 336-1,500,000 pg/mL
(IL-23), standard curve range: 37-150,000 pg/mL
(IL-22 & TNFβ), standard curve range: 488-2,000,000 pg/mL
(IL-17E/IL-25), standard curve range: 49-200,000 pg/mL
(IL-28a & IL-31), standard curve range: 5-20,000 pg/mL
(MIP-3α, IL-1β, IL-12 (p70), IL-15, IL-21 & IL-33), standard curve range: 6-25,000 pg/mL
(IL-5), standard curve range: 61-250,000 pg/mL
(GM-CSF & IL-27), standard curve range: 7-30,000 pg/mL
(IL-13), standard curve range: 9-35,000 pg/mL
(IL-9)

assay range

accuracy: 79-107%, standard curve range: 1-5000 pg/mL
(IL-10), standard curve range: 10-40,000 pg/mL
(IFNγ), standard curve range: 12-50,000 pg/mL
(IL-17A & IL-2), standard curve range: 24-100,000 pg/mL
(IL-17 & IL-4), standard curve range: 3-10,000 pg/mL
(IL-6 & TNFα), standard curve range: 336-1,500,000 pg/mL
(IL-23), standard curve range: 37-150,000 pg/mL
(IL-22 & TNFβ), standard curve range: 488-2,000,000 pg/mL
(IL-17E/IL-25), standard curve range: 49-200,000 pg/mL
(IL-28a & IL-31), standard curve range: 5-20,000 pg/mL
(MIP-3α, IL-1β, IL-12 (p70), IL-15, IL-21 & IL-33), standard curve range: 6-25,000 pg/mL
(IL-5), standard curve range: 61-250,000 pg/mL
(GM-CSF & IL-27), standard curve range: 7-30,000 pg/mL
(IL-13), standard curve range: 9-35,000 pg/mL
(IL-9)

assay range

accuracy: 85-110%, linearity: 111.0%
(1:04), linearity: 113.1%
(1:08), standard curve range: 1.5-1,500 pg/mL
(IL-4), standard curve range: 10-10,000 pg/mL
(IL-17F), standard curve range: 127-130,000 pg/mL
(IL-28B), standard curve range: 15-15,000 pg/mL
(IL-1β), standard curve range: 2.4-2,500 pg/mL
(IL-22), standard curve range: 20-20,000 pg/mL
(IL-10, IL-12(p70), & IL-21), standard curve range: 3.4-3,500 pg/mL
(TNFα), standard curve range: 34-35,000 pg/mL
(GM-CSF & IL-15), standard curve range: 342-350,000 pg/mL
(IL-23), standard curve range: 39-40,000 pg/mL
(IL-13 & IL-17A), standard curve range: 4.9-5,000 pg/mL
(IL-5), standard curve range: 488-500,000 pg/mL
(TNFβ), standard curve range: 49-50,000 pg/mL
(CD40L IL-31 & MIP-3α), standard curve range: 586-600,000 pg/mL
(IL-17E/ IL-25), standard curve range: 6.9-6,000 pg/mL
(IL-2), standard curve range: 7.8-8,000 pg/mL
(IFNγ & IL-6), standard curve range: 78-80,000 pg/mL
(IL-33), standard curve range: 879-900,000 pg/mL
(IL-27)

assay range

-

technique(s)

multiplexing: suitable

technique(s)

multiplexing: suitable

technique(s)

multiplexing: suitable

technique(s)

multiplexing: suitable

compatibility

configured for Premixed

compatibility

-

compatibility

configured for Premixed

compatibility

-

detection method

fluorometric (Luminex xMAP)

detection method

fluorometric (Luminex xMAP)

detection method

fluorometric (Luminex xMAP)

detection method

fluorometric (Luminex xMAP)

General description

CD4 T-helper cells are major players in adaptive immunity. Based on their expression profile of transcription factors and secreted cytokines, these cells are divided into the major subsets Th1, Th2, Th17 and T regulatory (Treg) cells. Th1 cells, induced by IL-12 and enhanced by IFNγ, secrete IFNγ that activates macrophages. Induced by IL-4, Th2 cells primarily produce IL-4, IL-5, IL-13, IL-25 and IL-17E, playing a role in allergy. Treg cells, induced by TGFβ, produce the anti-inflammatory cytokines IL-10 and TGFβ and function to control T-cell responses to prevent autoimmune reactions. Th17 cells, a more recently discovered subset characterized by the production of IL-17, are induced by TGFβ combined with IL-23 and IL-1β in humans, and TGFβ, IL-6 and IL-21 in mice. Activated Th17 cells secrete IL-17A, IL-17F, IL-21, IL-22 and TNFα to promote tissue inflammation.

Th17 cells are involved in the clearance of extracellular bacteria and fungi. They are abundant in the intestinal lamina propria and function as a barrier against invading pathogens. Excessive amounts of Th17 cells have been implicated in the pathogenesis of several autoimmune diseases, including multiple sclerosis, psoriasis, juvenile diabetes, rheumatoid arthritis, Crohn′s disease, and autoimmune uveitis. In addition, Th17 cells play an important role in tumor development, progression, and metastasis, potentially in both promoting and inhibiting tumor growth.

MILLIPLEX® Human TH17 Premixed Bead Panel is a 25-plex kit to be used for the simultaneous quantification of the following analytes in serum, plasma or culture supernatant samples: GM-CSF, IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 (p70), IL-13, IL-15, IL-17A, IL-17F, IL-17E/IL-25, IL-21, IL-22, IL-23, IL-27, IL-28A, IL-31, IL-33, MIP-3α/CCL20, TNF-α and TNFβ.

The Luminex® xMAP® platform uses a magnetic bead immunoassay format for ideal speed and sensitivity to quantitate multiple analytes simultaneously, dramatically improving productivity while conserving valuable sample volume.

Panel Type: Cytokines/Chemokines

Specificity

Cross Reactivty
Cross-reactivity between the antibodies and any of the other analytes in this panel is non-detectable or negligible.

Application

  • Analytes: GM-CSF, IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 (p70), IL-13, IL-15, IL-17A, IL-17F, IL-17E/IL-25, IL-21, IL-22, IL-23, IL-27, IL-28A, IL-31, IL-33, MIP-3α/CCL20, TNF-α, TNFβ
  • Recommended Sample type: Serum, plasma, and cell culture samples
  • Recommended Sample dilution: Neat
  • Assay Run Time: Overnight
  • Research Category: Inflammation & Immunology

Storage and Stability

Recommended storage for kit components is 2 - 8°C.

Other Notes

Sensitivity: Refer to kit protocol for sensitivities of individual biomarkers.

Legal Information

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Signal Word

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

Target Organs

Respiratory Tract

Storage Class Code

6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Documents related to the products that you have purchased in the past have been gathered in the Document Library for your convenience.

Visit the Document Library

Difficulty Finding Your Product Or Lot/Batch Number?

Product numbers are combined with Pack Sizes/Quantity when displayed on the website (example: T1503-25G). Please make sure you enter ONLY the product number in the Product Number field (example: T1503).

Example:

T1503
Product Number
-
25G
Pack Size/Quantity

Additional examples:

705578-5MG-PW

PL860-CGA/SHF-1EA

MMYOMAG-74K-13

1000309185

enter as 1.000309185)

Having trouble? Feel free to contact Technical Service for assistance.

Lot and Batch Numbers can be found on a product's label following the words 'Lot' or 'Batch'.

Aldrich Products

  • For a lot number such as TO09019TO, enter it as 09019TO (without the first two letters 'TO').

  • For a lot number with a filling-code such as 05427ES-021, enter it as 05427ES (without the filling-code '-021').

  • For a lot number with a filling-code such as STBB0728K9, enter it as STBB0728 without the filling-code 'K9'.

Not Finding What You Are Looking For?

In some cases, a COA may not be available online. If your search was unable to find the COA you can request one.

Request COA

Shereen Oon et al.
JCI insight, 1(6), e86131-e86131 (2016-10-05)
To date, the major target of biologic therapeutics in systemic lupus erythematosus (SLE) has been the B cell, which produces pathogenic autoantibodies. Recently, targeting type I IFN, which is elaborated by plasmacytoid dendritic cells (pDCs) in response to endosomal TLR7
Cather M Cala et al.
Journal of neuroimmunology, 297, 1-8 (2016-07-12)
Although multiple sclerosis is predominantly regarded as a disease of young adulthood, up to 5% of MS patients are diagnosed prior to age eighteen. The predominant form of MS is relapsing-remitting characterized by exacerbations of symptoms followed by periods of
Xiangcang Ye et al.
Cancer prevention research (Philadelphia, Pa.), 10(7), 398-409 (2017-05-10)
Chronic infection and associated inflammation have long been suspected to promote human carcinogenesis. Recently, certain gut bacteria, including some in the Fusobacterium genus, have been implicated in playing a role in human colorectal cancer development. However, the Fusobacterium species and
Gyoung Nyoun Kim et al.
PLoS pathogens, 17(12), e1010092-e1010092 (2021-12-17)
The development of safe and effective vaccines to prevent SARS-CoV-2 infections remains an urgent priority worldwide. We have used a recombinant vesicular stomatitis virus (rVSV)-based prime-boost immunization strategy to develop an effective COVID-19 vaccine candidate. We have constructed VSV genomes
Leena P Bharath et al.
Cell metabolism, 32(1), 44-55 (2020-05-14)
Age is a non-modifiable risk factor for the inflammation that underlies age-associated diseases; thus, anti-inflammaging drugs hold promise for increasing health span. Cytokine profiling and bioinformatic analyses showed that Th17 cytokine production differentiates CD4+ T cells from lean, normoglycemic older and

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service